Table 3 The ten most hypermethylated m6A modification peaks in CR and non-CR patients

mRNA

chr19

3,630,381

3,630,600

PIP5K1C

2.466541353

1.85476E−11

chr14

93,673,174

93,673,459

C14orf142

2.199620973

1.01067E−10

chr19

10,334,481

10,335,020

S1PR2

3.236576121

1.0939E−10

chr16

57,546,661

57,546,782

CCDC102A

5.4175

3.09279E−10

chr8

8,233,762

8,234,280

SGK223

2.391506444

8.10486E−10

chr6

29,640,761

29,640,960

ZFP57

147

1.08661E−09

chr21

46,396,594

46,396,660

FAM207A

3.407960199

1.45722E−09

chr16

3,534,941

3,535,260

NAA60

2.006998346

1.44972E−09

chr7

77,378,740

77,378,920

RSBN1L

3.446861405

1.56042E−09

chr19

49,813,296

49,813,423

SLC6A16

2.193574959

1.68245E−09

lncRNA

chr6

29,705,821

29,706,180

HLA-F-AS1

5.401433692

1.81634E−09

chr6

170,581,681

170,581,880

FLJ38122

10.92079208

3.6416E−09

chr22

28,396,961

28,397,200

TTC28-AS1

6.412244898

8.50001E−09

chr16

3,174,487

3,174,608

RP11-473M20.14

8.161616162

1.37529E−08

chr19

10,574,468

10,574,660

PDE4A

3.523758099

1.57046E−08

chr8

145,676,661

145,677,120

CYHR1

2.912176021

1.60788E−08

chr13

99,739,321

99,739,620

DOCK9-AS2

3.486910995

1.65164E−08

chr22

40,982,781

40,982,980

RPL4P6

6.583850932

2.08606E−08

chr17

80,212,181

80,212,380

CSNK1D

9.931506849

2.38251E−08

chr7

76,256,441

76,256,660

LOC100133091

6.496969697

2.39618E−08

circRNA

chr11

77,458,080

77,458,173

RSF1

2.478178368

8.05427E−06

chr11

17,332,371

17,332,557

NUCB2

2.39638865

6.07573E−06

chr9

74,360,181

74,360,495

TMEM2

2.040329617

5.49828E−06

chr9

710,803

710,880

KANK1

5.570093458

3.28767E−06

chr15

29,346,501

29,347,038

APBA2

2.013734114

2.69503E−06

chr4

106,157,201

106,157,480

TET2-AS1

2.497607656

2.19468E−06

chr6

42,750,421

42,750,680

GLTSCR1L

2.551066218

2.14826E−06

chr13

52,971,561

52,971,760

THSD1

5.216494845

2.1331E−06

chr19

50,222,713

50,222,880

G041290

2.594374236

1.7083E−06

chr6

7,414,501

7,414,623

RIOK1

2.760497667

1.44224E−06